HomeCompareNPRRF vs DIVO

NPRRF vs DIVO: Dividend Comparison 2026

NPRRF yields 1.90% · DIVO yields 6.62%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DIVO wins by $8.5K in total portfolio value
10 years
NPRRF
NPRRF
● Live price
1.90%
Share price
$9.96
Annual div
$0.19
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.5K
Annual income
$214.67
Full NPRRF calculator →
DIVO
DIVO
● Live price
6.62%
Share price
$44.00
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.0K
Annual income
$1,008.47
Full DIVO calculator →

Portfolio growth — NPRRF vs DIVO

📍 DIVO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNPRRFDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NPRRF + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NPRRF pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NPRRF
Annual income on $10K today (after 15% tax)
$161.38/yr
After 10yr DRIP, annual income (after tax)
$182.47/yr
DIVO
Annual income on $10K today (after 15% tax)
$562.67/yr
After 10yr DRIP, annual income (after tax)
$857.20/yr
At 15% tax rate, DIVO beats the other by $674.73/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NPRRF + DIVO for your $10,000?

NPRRF: 50%DIVO: 50%
100% DIVO50/50100% NPRRF
Portfolio after 10yr
$26.7K
Annual income
$611.58/yr
Blended yield
2.29%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NPRRF buys
0
DIVO buys
0
No recent congressional trades found for NPRRF or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNPRRFDIVO
Forward yield1.90%6.62%
Annual dividend / share$0.19$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$22.5K$31.0K
Annual income after 10y$214.67$1,008.47
Total dividends collected$2.0K$8.4K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: NPRRF vs DIVO ($10,000, DRIP)

YearNPRRF PortfolioNPRRF Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$10,890$189.86$11,362$661.96$472.00DIVO
2$11,845$193.23$12,860$702.91$1.0KDIVO
3$12,871$196.43$14,504$743.56$1.6KDIVO
4$13,971$199.48$16,303$783.73$2.3KDIVO
5$15,152$202.37$18,268$823.31$3.1KDIVO
6$16,418$205.11$20,408$862.17$4.0KDIVO
7$17,774$207.70$22,737$900.20$5.0KDIVO
8$19,229$210.16$25,266$937.31$6.0KDIVO
9$20,787$212.48$28,008$973.42$7.2KDIVO
10$22,457$214.67$30,977$1,008.47$8.5KDIVO

NPRRF vs DIVO: Complete Analysis 2026

NPRRFStock

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. The company's Medical Device business develops, manufactures, and sells medical equipment for injection-infusion and dialysis treatment, and products related to diabetes and cell cultures, as well as the sale of artificial organ-related products. Its Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations, as well as logistic and distribution services. The company's Pharma Packaging business offers glass products and other comprehensive pharmaceutical packaging, such as glass vials, ampoules, syringes, and cartridges; glass tubes; glass bulbs for vacuum flasks; and other parts of pharmaceutical packaging, such as rubber plugs. Its Other business provides thermostable enzymes for clinical chemistry. The company also offers business management services. Nipro Corporation serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Osaka, Japan.

Full NPRRF Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this NPRRF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NPRRF vs SCHDNPRRF vs JEPINPRRF vs ONPRRF vs KONPRRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.